PRCT241220P75000
- 0.23
- 0.000.00%
PROCEPT BioRobotics Newsroom
Leerink Partners Sticks to Their Buy Rating for PROCEPT BioRobotics (PRCT)
PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024
Express News | Procept Biorobotics Corp : Leerink Partners Cuts Target Price to $102 From $103
Alkermes, DaVita, Jabil, Ralph Lauren, Among Potential M&A Candidates - BofA
PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) 29% Jump Shows Its Popularity With Investors
Sector Update: Health Care Stocks Weaker Late Afternoon
PROCEPT Started With Hold at Jefferies on Valuation
Looking Into PROCEPT BioRobotics's Recent Short Interest
The Analyst Landscape: 6 Takes On PROCEPT BioRobotics
Jefferies Initiates PROCEPT BioRobotics(PRCT.US) With Hold Rating, Announces Target Price $95
Express News | Procept Biorobotics Corp : Jefferies Initiates Coverage With Hold Rating; Target Price $95
PROCEPT BioRobotics(PRCT.US) Director Sells US$9.63 Million in Common Stock
Are You Looking for a Top Momentum Pick? Why PROCEPT BioRobotics Corporation (PRCT) Is a Great Choice
Form 144 | PROCEPT BioRobotics(PRCT.US) Director Proposes to Sell 9.71 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 5, $PROCEPT BioRobotics(PRCT.US)$ Director 222 DNA TRUST intends to sell 100K shares of its common stock on Nov 5, with a total market value of approximately $9.71
Procept BioRobotics Insider Sold Shares Worth $26,249,951, According to a Recent SEC Filing
BofA Securities Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Announces Target Price $104
PROCEPT BioRobotics Analyst Ratings
Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Announces Target Price $105
PROCEPT BioRobotics Will Not Receive Any Proceeds From Any Sale of Shares by Selling Stockholder >PRCT
PROCEPT BioRobotics: Selling Stockholder Granted Underwriters 30-day Option to Purchase up to an Additional 288,461 Shares at the Public Offering Price >PRCT